New Research: Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience: Background Our study aimed to evaluate the efficacy of Tocilizumab and Abatacept for treating Childhood Chronic… https://t.co/Wi1J
3,952 followers
4,262 followers
Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience - Front Pediatr https://t.co/02emvTTxQq
138 followers
1-9-22: Florence, Italy: After methotrexate and Humira (adalimumab) had failed, there was a showdown between the all-purpose antioxidant, Actemra (tocilizumab), vs. Orencia (abatacept) for treating refractory Childhood Chronic Uveitis (CCU). Actemra won
138 followers
4-12-22: Florence, Italy: Showdown between the all-purpose antioxidant, Actemra (tocilizumab), and the rheumatoid arthritis drug, Orencia (abatacept), for treating refractory Childhood Chronic non-infectious Uveitis. Actemra won: https://t.co/q4pqYbe5MR